SD Biosensor Inc

SD Biosensor Inc has a liquidity position that appears to be medium risk, with a current ratio of 2.64 and cash and equivalents of KRW 366.8 billion. However, the company's free cash flow is negative at KRW -461.1 billion, and capital expenditures are also negative at KRW -57.5 billion, indicating ongoing investment in operations. The debt-to-equity ratio is 0.29, suggesting a relatively conservative capital structure with limited leverage. Profitability metrics for SD Biosensor Inc are negative, with a return on equity of -21.98% and a return on assets of -15.79%. These figures are significantly below the industry norms for medical equipment and supplies, which typically show positive returns. The company reported a net loss of KRW -512.1 billion and an operating loss of KRW -846.9 billion, indicating a challenging operating environment. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification beyond South Korea. This concentration increases exposure to local economic and regulatory risks. No material revenue is attributed to international operations. Looking ahead, SD Biosensor Inc is expected to face continued financial pressure, with a net loss in the current fiscal year and no clear indication of a turnaround in the next fiscal year. The company's operating cash flow of KRW 357.5 billion provides some buffer, but the negative free cash flow and capital expenditures suggest ongoing investment needs. The company's risk profile includes medium liquidity risk and low dilution risk. The key flag of negative net cash after subtracting total debt highlights the need for careful liquidity management. No significant dilution events are currently expected, and the number of shares outstanding remains stable. Recent filings and transcripts indicate that the company is actively managing its product pipeline and expanding its diagnostic offerings. However, the financial results suggest that these efforts have not yet translated into profitability. The company's ESG scores are moderate, with a social pillar score of 45.52 and a governance pillar score of 44.97, but a high ESG controversies score of 100.00, indicating no major controversies.